Baseline use of hydroxychloroquine in systemic lupus erythematosus does not preclude SARS-CoV-2 infection and severe COVID-19.
Identifieur interne : 001843 ( Main/Exploration ); précédent : 001842; suivant : 001844Baseline use of hydroxychloroquine in systemic lupus erythematosus does not preclude SARS-CoV-2 infection and severe COVID-19.
Auteurs : Maximilian F. Konig [États-Unis] ; Alfred Hj Kim [États-Unis] ; Marc H. Scheetz [États-Unis] ; Elizabeth R. Graef [États-Unis] ; Jean W. Liew [États-Unis] ; Julia Simard [États-Unis] ; Pedro M. Machado [Royaume-Uni] ; Milena Gianfrancesco [États-Unis] ; Jinoos Yazdany [États-Unis] ; Daman Langguth [Australie] ; Philip C. Robinson [États-Unis]Source :
- Annals of the rheumatic diseases [ 1468-2060 ] ; 2020.
Descripteurs français
- KwdFr :
- Adulte (MeSH), Adulte d'âge moyen (MeSH), Antirhumatismaux (sang), Antirhumatismaux (usage thérapeutique), Betacoronavirus (MeSH), Femelle (MeSH), Hospitalisation (statistiques et données numériques), Humains (MeSH), Hydroxychloroquine (sang), Hydroxychloroquine (usage thérapeutique), Indice de gravité de la maladie (MeSH), Infections à coronavirus (physiopathologie), Infections à coronavirus (thérapie), Infections à coronavirus (épidémiologie), Lupus érythémateux disséminé (traitement médicamenteux), Lupus érythémateux disséminé (épidémiologie), Mâle (MeSH), Oxygénation extracorporelle sur oxygénateur à membrane (statistiques et données numériques), Oxygénothérapie (MeSH), Pandémies (MeSH), Pneumopathie virale (physiopathologie), Pneumopathie virale (thérapie), Pneumopathie virale (épidémiologie), Relation dose-effet des médicaments (MeSH), Sujet âgé (MeSH), Ventilation artificielle (statistiques et données numériques), Études cas-témoins (MeSH).
- MESH :
- physiopathologie : Infections à coronavirus, Pneumopathie virale.
- sang : Antirhumatismaux, Hydroxychloroquine.
- statistiques et données numériques : Hospitalisation, Oxygénation extracorporelle sur oxygénateur à membrane, Ventilation artificielle.
- thérapie : Infections à coronavirus, Pneumopathie virale.
- traitement médicamenteux : Lupus érythémateux disséminé.
- usage thérapeutique : Antirhumatismaux, Hydroxychloroquine.
- épidémiologie : Infections à coronavirus, Lupus érythémateux disséminé, Pneumopathie virale.
- Adulte, Adulte d'âge moyen, Betacoronavirus, Femelle, Humains, Indice de gravité de la maladie, Mâle, Oxygénothérapie, Pandémies, Relation dose-effet des médicaments, Sujet âgé, Études cas-témoins.
English descriptors
- KwdEn :
- Adult (MeSH), Aged (MeSH), Antirheumatic Agents (blood), Antirheumatic Agents (therapeutic use), Betacoronavirus (MeSH), COVID-19 (MeSH), Case-Control Studies (MeSH), Coronavirus Infections (epidemiology), Coronavirus Infections (physiopathology), Coronavirus Infections (therapy), Dose-Response Relationship, Drug (MeSH), Extracorporeal Membrane Oxygenation (statistics & numerical data), Female (MeSH), Hospitalization (statistics & numerical data), Humans (MeSH), Hydroxychloroquine (blood), Hydroxychloroquine (therapeutic use), Lupus Erythematosus, Systemic (drug therapy), Lupus Erythematosus, Systemic (epidemiology), Male (MeSH), Middle Aged (MeSH), Oxygen Inhalation Therapy (MeSH), Pandemics (MeSH), Pneumonia, Viral (epidemiology), Pneumonia, Viral (physiopathology), Pneumonia, Viral (therapy), Respiration, Artificial (statistics & numerical data), SARS-CoV-2 (MeSH), Severity of Illness Index (MeSH).
- MESH :
- chemical , blood : Antirheumatic Agents, Hydroxychloroquine.
- chemical , therapeutic use : Antirheumatic Agents, Hydroxychloroquine.
- drug therapy : Lupus Erythematosus, Systemic.
- epidemiology : Coronavirus Infections, Lupus Erythematosus, Systemic, Pneumonia, Viral.
- physiopathology : Coronavirus Infections, Pneumonia, Viral.
- statistics & numerical data : Extracorporeal Membrane Oxygenation, Hospitalization, Respiration, Artificial.
- therapy : Coronavirus Infections, Pneumonia, Viral.
- Adult, Aged, Betacoronavirus, COVID-19, Case-Control Studies, Dose-Response Relationship, Drug, Female, Humans, Male, Middle Aged, Oxygen Inhalation Therapy, Pandemics, SARS-CoV-2, Severity of Illness Index.
DOI: 10.1136/annrheumdis-2020-217690
PubMed: 32381561
Affiliations:
- Australie, Royaume-Uni, États-Unis
- Angleterre, Californie, Grand Londres, Illinois, Maryland, Massachusetts, Missouri (État), Washington (État)
- Londres, Saint-Louis (Missouri), Seattle
- University College de Londres, Université de Washington, École de médecine (Université Washington de Saint-Louis)
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Baseline use of hydroxychloroquine in systemic lupus erythematosus does not preclude SARS-CoV-2 infection and severe COVID-19.</title><author><name sortKey="Konig, Maximilian F" sort="Konig, Maximilian F" uniqKey="Konig M" first="Maximilian F" last="Konig">Maximilian F. Konig</name><affiliation wicri:level="2"><nlm:affiliation>Division of Rheumatology, Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA konig@jhmi.edu philip.robinson@uq.edu.au.</nlm:affiliation><country wicri:rule="url">États-Unis</country><wicri:regionArea>Division of Rheumatology, Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, Maryland</wicri:regionArea><placeName><region type="state">Maryland</region></placeName></affiliation></author><author><name sortKey="Kim, Alfred Hj" sort="Kim, Alfred Hj" uniqKey="Kim A" first="Alfred Hj" last="Kim">Alfred Hj Kim</name><affiliation wicri:level="4"><nlm:affiliation>Division of Rheumatology, Department of Medicine, Washington University School of Medicine, Saint Louis, Missouri, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Division of Rheumatology, Department of Medicine, Washington University School of Medicine, Saint Louis, Missouri</wicri:regionArea><placeName><region type="state">Missouri (État)</region><settlement type="city">Saint-Louis (Missouri)</settlement></placeName><orgName type="university">École de médecine (Université Washington de Saint-Louis)</orgName></affiliation><affiliation wicri:level="4"><nlm:affiliation>Division of Immunobiology, Department of Pathology and Immunology, Washington University School of Medicine, Saint Louis, Missouri, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Division of Immunobiology, Department of Pathology and Immunology, Washington University School of Medicine, Saint Louis, Missouri</wicri:regionArea><placeName><region type="state">Missouri (État)</region><settlement type="city">Saint-Louis (Missouri)</settlement></placeName><orgName type="university">École de médecine (Université Washington de Saint-Louis)</orgName></affiliation><affiliation wicri:level="4"><nlm:affiliation>Andrew M. and Jane M. Bursky Center of Human Immunology and Immunotherapy Programs, Washington University School of Medicine, Saint Louis, Missouri, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Andrew M. and Jane M. Bursky Center of Human Immunology and Immunotherapy Programs, Washington University School of Medicine, Saint Louis, Missouri</wicri:regionArea><placeName><region type="state">Missouri (État)</region><settlement type="city">Saint-Louis (Missouri)</settlement></placeName><orgName type="university">École de médecine (Université Washington de Saint-Louis)</orgName></affiliation></author><author><name sortKey="Scheetz, Marc H" sort="Scheetz, Marc H" uniqKey="Scheetz M" first="Marc H" last="Scheetz">Marc H. Scheetz</name><affiliation wicri:level="2"><nlm:affiliation>Departments of Pharmacy Practice and Pharmacology; Pharmacometrics Center of Excellence, Midwestern University, Chicago College of Pharmacy, and College of Graduate Studies, Downers Grove, Illinois, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Departments of Pharmacy Practice and Pharmacology; Pharmacometrics Center of Excellence, Midwestern University, Chicago College of Pharmacy, and College of Graduate Studies, Downers Grove, Illinois</wicri:regionArea><placeName><region type="state">Illinois</region></placeName></affiliation><affiliation wicri:level="2"><nlm:affiliation>Department of Pharmacy, Northwestern Memorial Hospital, Chicago, Illinois, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Pharmacy, Northwestern Memorial Hospital, Chicago, Illinois</wicri:regionArea><placeName><region type="state">Illinois</region></placeName></affiliation></author><author><name sortKey="Graef, Elizabeth R" sort="Graef, Elizabeth R" uniqKey="Graef E" first="Elizabeth R" last="Graef">Elizabeth R. Graef</name><affiliation wicri:level="2"><nlm:affiliation>Division of Rheumatology and Clinical Immunology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Division of Rheumatology and Clinical Immunology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts</wicri:regionArea><placeName><region type="state">Massachusetts</region></placeName></affiliation></author><author><name sortKey="Liew, Jean W" sort="Liew, Jean W" uniqKey="Liew J" first="Jean W" last="Liew">Jean W. Liew</name><affiliation wicri:level="4"><nlm:affiliation>Division of Rheumatology, Department of Medicine, University of Washington, Seattle, Washington, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Division of Rheumatology, Department of Medicine, University of Washington, Seattle, Washington</wicri:regionArea><placeName><region type="state">Washington (État)</region><settlement type="city">Seattle</settlement></placeName><orgName type="university">Université de Washington</orgName></affiliation></author><author><name sortKey="Simard, Julia" sort="Simard, Julia" uniqKey="Simard J" first="Julia" last="Simard">Julia Simard</name><affiliation wicri:level="2"><nlm:affiliation>Department of Epidemiology & Population Health; Department of Medicine, Division of Immunology & Rheumatology, Stanford University School of Medicine, Stanford, California, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Epidemiology & Population Health; Department of Medicine, Division of Immunology & Rheumatology, Stanford University School of Medicine, Stanford, California</wicri:regionArea><placeName><region type="state">Californie</region></placeName></affiliation></author><author><name sortKey="Machado, Pedro M" sort="Machado, Pedro M" uniqKey="Machado P" first="Pedro M" last="Machado">Pedro M. Machado</name><affiliation wicri:level="4"><nlm:affiliation>Centre for Rheumatology & Department of Neuromuscular Diseases, University College London, London, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Centre for Rheumatology & Department of Neuromuscular Diseases, University College London, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName><orgName type="university">University College de Londres</orgName></affiliation><affiliation wicri:level="3"><nlm:affiliation>Department of Rheumatology & Queen Square Centre for Neuromuscular Diseases, University College London Hospitals NHS Foundation Trust, London, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Department of Rheumatology & Queen Square Centre for Neuromuscular Diseases, University College London Hospitals NHS Foundation Trust, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation><affiliation wicri:level="3"><nlm:affiliation>Department of Rheumatology, Northwick Park Hospital, London North West University Healthcare NHS Trust, London, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Department of Rheumatology, Northwick Park Hospital, London North West University Healthcare NHS Trust, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation></author><author><name sortKey="Gianfrancesco, Milena" sort="Gianfrancesco, Milena" uniqKey="Gianfrancesco M" first="Milena" last="Gianfrancesco">Milena Gianfrancesco</name><affiliation wicri:level="2"><nlm:affiliation>Division of Rheumatology, Department of Medicine, University of California San Francisco, San Francisco, California, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Division of Rheumatology, Department of Medicine, University of California San Francisco, San Francisco, California</wicri:regionArea><placeName><region type="state">Californie</region></placeName></affiliation></author><author><name sortKey="Yazdany, Jinoos" sort="Yazdany, Jinoos" uniqKey="Yazdany J" first="Jinoos" last="Yazdany">Jinoos Yazdany</name><affiliation wicri:level="2"><nlm:affiliation>Division of Rheumatology, Department of Medicine, University of California San Francisco, San Francisco, California, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Division of Rheumatology, Department of Medicine, University of California San Francisco, San Francisco, California</wicri:regionArea><placeName><region type="state">Californie</region></placeName></affiliation></author><author><name sortKey="Langguth, Daman" sort="Langguth, Daman" uniqKey="Langguth D" first="Daman" last="Langguth">Daman Langguth</name><affiliation wicri:level="1"><nlm:affiliation>Department of Immunology, Sullivan Nicolaides Pathology, Brisbane, Queensland, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Department of Immunology, Sullivan Nicolaides Pathology, Brisbane, Queensland</wicri:regionArea><wicri:noRegion>Queensland</wicri:noRegion></affiliation></author><author><name sortKey="Robinson, Philip C" sort="Robinson, Philip C" uniqKey="Robinson P" first="Philip C" last="Robinson">Philip C. Robinson</name><affiliation wicri:level="1"><nlm:affiliation>The University of Queensland Faculty of Medicine, Brisbane, Queensland, Australia konig@jhmi.edu philip.robinson@uq.edu.au.</nlm:affiliation><country wicri:rule="url">États-Unis</country><wicri:regionArea>The University of Queensland Faculty of Medicine, Brisbane, Queensland</wicri:regionArea><wicri:noRegion>Queensland</wicri:noRegion></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020</date><idno type="RBID">pubmed:32381561</idno><idno type="pmid">32381561</idno><idno type="doi">10.1136/annrheumdis-2020-217690</idno><idno type="wicri:Area/Main/Corpus">001764</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">001764</idno><idno type="wicri:Area/Main/Curation">001764</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">001764</idno><idno type="wicri:Area/Main/Exploration">001764</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Baseline use of hydroxychloroquine in systemic lupus erythematosus does not preclude SARS-CoV-2 infection and severe COVID-19.</title><author><name sortKey="Konig, Maximilian F" sort="Konig, Maximilian F" uniqKey="Konig M" first="Maximilian F" last="Konig">Maximilian F. Konig</name><affiliation wicri:level="2"><nlm:affiliation>Division of Rheumatology, Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA konig@jhmi.edu philip.robinson@uq.edu.au.</nlm:affiliation><country wicri:rule="url">États-Unis</country><wicri:regionArea>Division of Rheumatology, Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, Maryland</wicri:regionArea><placeName><region type="state">Maryland</region></placeName></affiliation></author><author><name sortKey="Kim, Alfred Hj" sort="Kim, Alfred Hj" uniqKey="Kim A" first="Alfred Hj" last="Kim">Alfred Hj Kim</name><affiliation wicri:level="4"><nlm:affiliation>Division of Rheumatology, Department of Medicine, Washington University School of Medicine, Saint Louis, Missouri, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Division of Rheumatology, Department of Medicine, Washington University School of Medicine, Saint Louis, Missouri</wicri:regionArea><placeName><region type="state">Missouri (État)</region><settlement type="city">Saint-Louis (Missouri)</settlement></placeName><orgName type="university">École de médecine (Université Washington de Saint-Louis)</orgName></affiliation><affiliation wicri:level="4"><nlm:affiliation>Division of Immunobiology, Department of Pathology and Immunology, Washington University School of Medicine, Saint Louis, Missouri, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Division of Immunobiology, Department of Pathology and Immunology, Washington University School of Medicine, Saint Louis, Missouri</wicri:regionArea><placeName><region type="state">Missouri (État)</region><settlement type="city">Saint-Louis (Missouri)</settlement></placeName><orgName type="university">École de médecine (Université Washington de Saint-Louis)</orgName></affiliation><affiliation wicri:level="4"><nlm:affiliation>Andrew M. and Jane M. Bursky Center of Human Immunology and Immunotherapy Programs, Washington University School of Medicine, Saint Louis, Missouri, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Andrew M. and Jane M. Bursky Center of Human Immunology and Immunotherapy Programs, Washington University School of Medicine, Saint Louis, Missouri</wicri:regionArea><placeName><region type="state">Missouri (État)</region><settlement type="city">Saint-Louis (Missouri)</settlement></placeName><orgName type="university">École de médecine (Université Washington de Saint-Louis)</orgName></affiliation></author><author><name sortKey="Scheetz, Marc H" sort="Scheetz, Marc H" uniqKey="Scheetz M" first="Marc H" last="Scheetz">Marc H. Scheetz</name><affiliation wicri:level="2"><nlm:affiliation>Departments of Pharmacy Practice and Pharmacology; Pharmacometrics Center of Excellence, Midwestern University, Chicago College of Pharmacy, and College of Graduate Studies, Downers Grove, Illinois, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Departments of Pharmacy Practice and Pharmacology; Pharmacometrics Center of Excellence, Midwestern University, Chicago College of Pharmacy, and College of Graduate Studies, Downers Grove, Illinois</wicri:regionArea><placeName><region type="state">Illinois</region></placeName></affiliation><affiliation wicri:level="2"><nlm:affiliation>Department of Pharmacy, Northwestern Memorial Hospital, Chicago, Illinois, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Pharmacy, Northwestern Memorial Hospital, Chicago, Illinois</wicri:regionArea><placeName><region type="state">Illinois</region></placeName></affiliation></author><author><name sortKey="Graef, Elizabeth R" sort="Graef, Elizabeth R" uniqKey="Graef E" first="Elizabeth R" last="Graef">Elizabeth R. Graef</name><affiliation wicri:level="2"><nlm:affiliation>Division of Rheumatology and Clinical Immunology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Division of Rheumatology and Clinical Immunology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts</wicri:regionArea><placeName><region type="state">Massachusetts</region></placeName></affiliation></author><author><name sortKey="Liew, Jean W" sort="Liew, Jean W" uniqKey="Liew J" first="Jean W" last="Liew">Jean W. Liew</name><affiliation wicri:level="4"><nlm:affiliation>Division of Rheumatology, Department of Medicine, University of Washington, Seattle, Washington, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Division of Rheumatology, Department of Medicine, University of Washington, Seattle, Washington</wicri:regionArea><placeName><region type="state">Washington (État)</region><settlement type="city">Seattle</settlement></placeName><orgName type="university">Université de Washington</orgName></affiliation></author><author><name sortKey="Simard, Julia" sort="Simard, Julia" uniqKey="Simard J" first="Julia" last="Simard">Julia Simard</name><affiliation wicri:level="2"><nlm:affiliation>Department of Epidemiology & Population Health; Department of Medicine, Division of Immunology & Rheumatology, Stanford University School of Medicine, Stanford, California, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Epidemiology & Population Health; Department of Medicine, Division of Immunology & Rheumatology, Stanford University School of Medicine, Stanford, California</wicri:regionArea><placeName><region type="state">Californie</region></placeName></affiliation></author><author><name sortKey="Machado, Pedro M" sort="Machado, Pedro M" uniqKey="Machado P" first="Pedro M" last="Machado">Pedro M. Machado</name><affiliation wicri:level="4"><nlm:affiliation>Centre for Rheumatology & Department of Neuromuscular Diseases, University College London, London, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Centre for Rheumatology & Department of Neuromuscular Diseases, University College London, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName><orgName type="university">University College de Londres</orgName></affiliation><affiliation wicri:level="3"><nlm:affiliation>Department of Rheumatology & Queen Square Centre for Neuromuscular Diseases, University College London Hospitals NHS Foundation Trust, London, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Department of Rheumatology & Queen Square Centre for Neuromuscular Diseases, University College London Hospitals NHS Foundation Trust, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation><affiliation wicri:level="3"><nlm:affiliation>Department of Rheumatology, Northwick Park Hospital, London North West University Healthcare NHS Trust, London, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Department of Rheumatology, Northwick Park Hospital, London North West University Healthcare NHS Trust, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation></author><author><name sortKey="Gianfrancesco, Milena" sort="Gianfrancesco, Milena" uniqKey="Gianfrancesco M" first="Milena" last="Gianfrancesco">Milena Gianfrancesco</name><affiliation wicri:level="2"><nlm:affiliation>Division of Rheumatology, Department of Medicine, University of California San Francisco, San Francisco, California, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Division of Rheumatology, Department of Medicine, University of California San Francisco, San Francisco, California</wicri:regionArea><placeName><region type="state">Californie</region></placeName></affiliation></author><author><name sortKey="Yazdany, Jinoos" sort="Yazdany, Jinoos" uniqKey="Yazdany J" first="Jinoos" last="Yazdany">Jinoos Yazdany</name><affiliation wicri:level="2"><nlm:affiliation>Division of Rheumatology, Department of Medicine, University of California San Francisco, San Francisco, California, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Division of Rheumatology, Department of Medicine, University of California San Francisco, San Francisco, California</wicri:regionArea><placeName><region type="state">Californie</region></placeName></affiliation></author><author><name sortKey="Langguth, Daman" sort="Langguth, Daman" uniqKey="Langguth D" first="Daman" last="Langguth">Daman Langguth</name><affiliation wicri:level="1"><nlm:affiliation>Department of Immunology, Sullivan Nicolaides Pathology, Brisbane, Queensland, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Department of Immunology, Sullivan Nicolaides Pathology, Brisbane, Queensland</wicri:regionArea><wicri:noRegion>Queensland</wicri:noRegion></affiliation></author><author><name sortKey="Robinson, Philip C" sort="Robinson, Philip C" uniqKey="Robinson P" first="Philip C" last="Robinson">Philip C. Robinson</name><affiliation wicri:level="1"><nlm:affiliation>The University of Queensland Faculty of Medicine, Brisbane, Queensland, Australia konig@jhmi.edu philip.robinson@uq.edu.au.</nlm:affiliation><country wicri:rule="url">États-Unis</country><wicri:regionArea>The University of Queensland Faculty of Medicine, Brisbane, Queensland</wicri:regionArea><wicri:noRegion>Queensland</wicri:noRegion></affiliation></author></analytic><series><title level="j">Annals of the rheumatic diseases</title><idno type="eISSN">1468-2060</idno><imprint><date when="2020" type="published">2020</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult (MeSH)</term><term>Aged (MeSH)</term><term>Antirheumatic Agents (blood)</term><term>Antirheumatic Agents (therapeutic use)</term><term>Betacoronavirus (MeSH)</term><term>COVID-19 (MeSH)</term><term>Case-Control Studies (MeSH)</term><term>Coronavirus Infections (epidemiology)</term><term>Coronavirus Infections (physiopathology)</term><term>Coronavirus Infections (therapy)</term><term>Dose-Response Relationship, Drug (MeSH)</term><term>Extracorporeal Membrane Oxygenation (statistics & numerical data)</term><term>Female (MeSH)</term><term>Hospitalization (statistics & numerical data)</term><term>Humans (MeSH)</term><term>Hydroxychloroquine (blood)</term><term>Hydroxychloroquine (therapeutic use)</term><term>Lupus Erythematosus, Systemic (drug therapy)</term><term>Lupus Erythematosus, Systemic (epidemiology)</term><term>Male (MeSH)</term><term>Middle Aged (MeSH)</term><term>Oxygen Inhalation Therapy (MeSH)</term><term>Pandemics (MeSH)</term><term>Pneumonia, Viral (epidemiology)</term><term>Pneumonia, Viral (physiopathology)</term><term>Pneumonia, Viral (therapy)</term><term>Respiration, Artificial (statistics & numerical data)</term><term>SARS-CoV-2 (MeSH)</term><term>Severity of Illness Index (MeSH)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte (MeSH)</term><term>Adulte d'âge moyen (MeSH)</term><term>Antirhumatismaux (sang)</term><term>Antirhumatismaux (usage thérapeutique)</term><term>Betacoronavirus (MeSH)</term><term>Femelle (MeSH)</term><term>Hospitalisation (statistiques et données numériques)</term><term>Humains (MeSH)</term><term>Hydroxychloroquine (sang)</term><term>Hydroxychloroquine (usage thérapeutique)</term><term>Indice de gravité de la maladie (MeSH)</term><term>Infections à coronavirus (physiopathologie)</term><term>Infections à coronavirus (thérapie)</term><term>Infections à coronavirus (épidémiologie)</term><term>Lupus érythémateux disséminé (traitement médicamenteux)</term><term>Lupus érythémateux disséminé (épidémiologie)</term><term>Mâle (MeSH)</term><term>Oxygénation extracorporelle sur oxygénateur à membrane (statistiques et données numériques)</term><term>Oxygénothérapie (MeSH)</term><term>Pandémies (MeSH)</term><term>Pneumopathie virale (physiopathologie)</term><term>Pneumopathie virale (thérapie)</term><term>Pneumopathie virale (épidémiologie)</term><term>Relation dose-effet des médicaments (MeSH)</term><term>Sujet âgé (MeSH)</term><term>Ventilation artificielle (statistiques et données numériques)</term><term>Études cas-témoins (MeSH)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="blood" xml:lang="en"><term>Antirheumatic Agents</term><term>Hydroxychloroquine</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antirheumatic Agents</term><term>Hydroxychloroquine</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Lupus Erythematosus, Systemic</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Coronavirus Infections</term><term>Lupus Erythematosus, Systemic</term><term>Pneumonia, Viral</term></keywords><keywords scheme="MESH" qualifier="physiopathologie" xml:lang="fr"><term>Infections à coronavirus</term><term>Pneumopathie virale</term></keywords><keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Coronavirus Infections</term><term>Pneumonia, Viral</term></keywords><keywords scheme="MESH" qualifier="sang" xml:lang="fr"><term>Antirhumatismaux</term><term>Hydroxychloroquine</term></keywords><keywords scheme="MESH" qualifier="statistics & numerical data" xml:lang="en"><term>Extracorporeal Membrane Oxygenation</term><term>Hospitalization</term><term>Respiration, Artificial</term></keywords><keywords scheme="MESH" qualifier="statistiques et données numériques" xml:lang="fr"><term>Hospitalisation</term><term>Oxygénation extracorporelle sur oxygénateur à membrane</term><term>Ventilation artificielle</term></keywords><keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Coronavirus Infections</term><term>Pneumonia, Viral</term></keywords><keywords scheme="MESH" qualifier="thérapie" xml:lang="fr"><term>Infections à coronavirus</term><term>Pneumopathie virale</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Lupus érythémateux disséminé</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Antirhumatismaux</term><term>Hydroxychloroquine</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Infections à coronavirus</term><term>Lupus érythémateux disséminé</term><term>Pneumopathie virale</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Aged</term><term>Betacoronavirus</term><term>COVID-19</term><term>Case-Control Studies</term><term>Dose-Response Relationship, Drug</term><term>Female</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Oxygen Inhalation Therapy</term><term>Pandemics</term><term>SARS-CoV-2</term><term>Severity of Illness Index</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte</term><term>Adulte d'âge moyen</term><term>Betacoronavirus</term><term>Femelle</term><term>Humains</term><term>Indice de gravité de la maladie</term><term>Mâle</term><term>Oxygénothérapie</term><term>Pandémies</term><term>Relation dose-effet des médicaments</term><term>Sujet âgé</term><term>Études cas-témoins</term></keywords></textClass></profileDesc></teiHeader></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32381561</PMID><DateCompleted><Year>2020</Year><Month>09</Month><Day>24</Day></DateCompleted><DateRevised><Year>2020</Year><Month>12</Month><Day>18</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1468-2060</ISSN><JournalIssue CitedMedium="Internet"><Volume>79</Volume><Issue>10</Issue><PubDate><Year>2020</Year><Month>10</Month></PubDate></JournalIssue><Title>Annals of the rheumatic diseases</Title><ISOAbbreviation>Ann Rheum Dis</ISOAbbreviation></Journal><ArticleTitle>Baseline use of hydroxychloroquine in systemic lupus erythematosus does not preclude SARS-CoV-2 infection and severe COVID-19.</ArticleTitle><Pagination><MedlinePgn>1386-1388</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1136/annrheumdis-2020-217690</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Konig</LastName><ForeName>Maximilian F</ForeName><Initials>MF</Initials><Identifier Source="ORCID">0000-0001-5045-5255</Identifier><AffiliationInfo><Affiliation>Division of Rheumatology, Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA konig@jhmi.edu philip.robinson@uq.edu.au.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Alfred Hj</ForeName><Initials>AH</Initials><Identifier Source="ORCID">0000-0003-4074-0516</Identifier><AffiliationInfo><Affiliation>Division of Rheumatology, Department of Medicine, Washington University School of Medicine, Saint Louis, Missouri, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Immunobiology, Department of Pathology and Immunology, Washington University School of Medicine, Saint Louis, Missouri, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Andrew M. and Jane M. Bursky Center of Human Immunology and Immunotherapy Programs, Washington University School of Medicine, Saint Louis, Missouri, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scheetz</LastName><ForeName>Marc H</ForeName><Initials>MH</Initials><AffiliationInfo><Affiliation>Departments of Pharmacy Practice and Pharmacology; Pharmacometrics Center of Excellence, Midwestern University, Chicago College of Pharmacy, and College of Graduate Studies, Downers Grove, Illinois, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pharmacy, Northwestern Memorial Hospital, Chicago, Illinois, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Graef</LastName><ForeName>Elizabeth R</ForeName><Initials>ER</Initials><AffiliationInfo><Affiliation>Division of Rheumatology and Clinical Immunology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liew</LastName><ForeName>Jean W</ForeName><Initials>JW</Initials><AffiliationInfo><Affiliation>Division of Rheumatology, Department of Medicine, University of Washington, Seattle, Washington, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Simard</LastName><ForeName>Julia</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Epidemiology & Population Health; Department of Medicine, Division of Immunology & Rheumatology, Stanford University School of Medicine, Stanford, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Machado</LastName><ForeName>Pedro M</ForeName><Initials>PM</Initials><Identifier Source="ORCID">0000-0002-8411-7972</Identifier><AffiliationInfo><Affiliation>Centre for Rheumatology & Department of Neuromuscular Diseases, University College London, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Rheumatology & Queen Square Centre for Neuromuscular Diseases, University College London Hospitals NHS Foundation Trust, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Rheumatology, Northwick Park Hospital, London North West University Healthcare NHS Trust, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gianfrancesco</LastName><ForeName>Milena</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Rheumatology, Department of Medicine, University of California San Francisco, San Francisco, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yazdany</LastName><ForeName>Jinoos</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Division of Rheumatology, Department of Medicine, University of California San Francisco, San Francisco, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Langguth</LastName><ForeName>Daman</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Immunology, Sullivan Nicolaides Pathology, Brisbane, Queensland, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Robinson</LastName><ForeName>Philip C</ForeName><Initials>PC</Initials><Identifier Source="ORCID">0000-0002-3156-3418</Identifier><AffiliationInfo><Affiliation>The University of Queensland Faculty of Medicine, Brisbane, Queensland, Australia konig@jhmi.edu philip.robinson@uq.edu.au.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>COVID-19 Global Rheumatology Alliance</CollectiveName></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P30 AR073752</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 AR048522</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 AR070155</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K24 AR074534</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>L30 AR072421</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016422">Letter</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>05</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Ann Rheum Dis</MedlineTA><NlmUniqueID>0372355</NlmUniqueID><ISSNLinking>0003-4967</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018501">Antirheumatic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>4QWG6N8QKH</RegistryNumber><NameOfSubstance UI="D006886">Hydroxychloroquine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018501" MajorTopicYN="N">Antirheumatic Agents</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000073640" MajorTopicYN="N">Betacoronavirus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004305" MajorTopicYN="N">Dose-Response Relationship, Drug</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015199" MajorTopicYN="N">Extracorporeal Membrane Oxygenation</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics & numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics & numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006886" MajorTopicYN="N">Hydroxychloroquine</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="N">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010102" MajorTopicYN="N">Oxygen Inhalation Therapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011024" MajorTopicYN="N">Pneumonia, Viral</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012121" MajorTopicYN="N">Respiration, Artificial</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics & numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">epidemiology</Keyword><Keyword MajorTopicYN="Y">hydroxychloroquine</Keyword><Keyword MajorTopicYN="Y">lupus erythematosus, systemic</Keyword><Keyword MajorTopicYN="Y">pharmacokinetics</Keyword></KeywordList><CoiStatement>Competing interests: MFK received personal fees from Bristol-Myers Squibb and Celltrion, unrelated to this manuscript. AHK received personal fees from Exagen Diagnostics, Inc and GlaxoSmithKline, unrelated to this manuscript. PMM received personal fees from Abbvie, Eli Lilly, Novartis and UCB Pharma. JY received personal fees from Astra Zeneca and Eli Lilly, unrelated to this manuscript. PCR reports personal fees from Abbvie, Pfizer, UCB Pharma, Novartis, Eli Lilly and Janssen, and non-financial support from Roche.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>04</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>04</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>04</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>5</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>9</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>5</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32381561</ArticleId><ArticleId IdType="pii">annrheumdis-2020-217690</ArticleId><ArticleId IdType="doi">10.1136/annrheumdis-2020-217690</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>Australie</li><li>Royaume-Uni</li><li>États-Unis</li></country><region><li>Angleterre</li><li>Californie</li><li>Grand Londres</li><li>Illinois</li><li>Maryland</li><li>Massachusetts</li><li>Missouri (État)</li><li>Washington (État)</li></region><settlement><li>Londres</li><li>Saint-Louis (Missouri)</li><li>Seattle</li></settlement><orgName><li>University College de Londres</li><li>Université de Washington</li><li>École de médecine (Université Washington de Saint-Louis)</li></orgName></list><tree><country name="États-Unis"><region name="Maryland"><name sortKey="Konig, Maximilian F" sort="Konig, Maximilian F" uniqKey="Konig M" first="Maximilian F" last="Konig">Maximilian F. Konig</name></region><name sortKey="Gianfrancesco, Milena" sort="Gianfrancesco, Milena" uniqKey="Gianfrancesco M" first="Milena" last="Gianfrancesco">Milena Gianfrancesco</name><name sortKey="Graef, Elizabeth R" sort="Graef, Elizabeth R" uniqKey="Graef E" first="Elizabeth R" last="Graef">Elizabeth R. Graef</name><name sortKey="Kim, Alfred Hj" sort="Kim, Alfred Hj" uniqKey="Kim A" first="Alfred Hj" last="Kim">Alfred Hj Kim</name><name sortKey="Kim, Alfred Hj" sort="Kim, Alfred Hj" uniqKey="Kim A" first="Alfred Hj" last="Kim">Alfred Hj Kim</name><name sortKey="Kim, Alfred Hj" sort="Kim, Alfred Hj" uniqKey="Kim A" first="Alfred Hj" last="Kim">Alfred Hj Kim</name><name sortKey="Liew, Jean W" sort="Liew, Jean W" uniqKey="Liew J" first="Jean W" last="Liew">Jean W. Liew</name><name sortKey="Robinson, Philip C" sort="Robinson, Philip C" uniqKey="Robinson P" first="Philip C" last="Robinson">Philip C. Robinson</name><name sortKey="Scheetz, Marc H" sort="Scheetz, Marc H" uniqKey="Scheetz M" first="Marc H" last="Scheetz">Marc H. Scheetz</name><name sortKey="Scheetz, Marc H" sort="Scheetz, Marc H" uniqKey="Scheetz M" first="Marc H" last="Scheetz">Marc H. Scheetz</name><name sortKey="Simard, Julia" sort="Simard, Julia" uniqKey="Simard J" first="Julia" last="Simard">Julia Simard</name><name sortKey="Yazdany, Jinoos" sort="Yazdany, Jinoos" uniqKey="Yazdany J" first="Jinoos" last="Yazdany">Jinoos Yazdany</name></country><country name="Royaume-Uni"><region name="Angleterre"><name sortKey="Machado, Pedro M" sort="Machado, Pedro M" uniqKey="Machado P" first="Pedro M" last="Machado">Pedro M. Machado</name></region><name sortKey="Machado, Pedro M" sort="Machado, Pedro M" uniqKey="Machado P" first="Pedro M" last="Machado">Pedro M. Machado</name><name sortKey="Machado, Pedro M" sort="Machado, Pedro M" uniqKey="Machado P" first="Pedro M" last="Machado">Pedro M. Machado</name></country><country name="Australie"><noRegion><name sortKey="Langguth, Daman" sort="Langguth, Daman" uniqKey="Langguth D" first="Daman" last="Langguth">Daman Langguth</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001843 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001843 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= CovidChloroV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:32381561
|texte= Baseline use of hydroxychloroquine in systemic lupus erythematosus does not preclude SARS-CoV-2 infection and severe COVID-19.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:32381561" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a CovidChloroV1
| This area was generated with Dilib version V0.6.38. |  |